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We report a case of very late stent thrombosis 7 years post sirolimus eluting stent im-
plantation presenting as ST elevation MI while on dual antiplatelet therapy. Angiography
revealed an aneurysm at the proximal end of the stent. The patient was managed suc-
cessfully by primary percutaneous coronary intervention (PCI) with adjunct thrombus
aspiration and intracoronary abciximab administration followed by deploying a mesh-
covered stent MGuard. This very late complication is a rare presentation after a drug
illuting stent (DES).
Copyright ª 2014, Cardiological Society of India. All rights reserved.1. Introduction
Historically coronary artery aneurysmswere first described by
Morgagni in 1761.1,2 Coronary artery aneurysm, defined as
dilatation of the coronary artery exceeding 50% of the refer-
ence vessel diameter, is uncommon and occurs in less than
5% of coronary angiographic series.3
We report a rare case of coronary aneurysm presenting as
acute ST elevation MI (STEMI) secondary to very late stent
thrombosis (VLST) 7 years after implantation of a first gener-
ation sirolimus eluting stent (SES) implantation.2. Case report
A 52-year-old male normotensive, non-diabetic, non-smoker
having strong family history of coronary artery disease (CAD)(U. Kaul).
ciety of India. All rightshad effort angina in August 2006. Treadmill test (TMT) done
subsequently was positive reversible myocardial ischemia
(RMI). Coronary angiography done same month was sugges-
tive of Double vessel disease: Left anterior descending artery
(LAD) 90%mid segment stenosis and Left circumflex (LCX) 90%
proximal and extending into a large obtuse marginal branch.
Subsequently patient underwent angioplasty with stenting
using a sirolimus eluting stent (Cypher) 3  13 mm to LAD, a
Zotarolimus eluting stent (Endeavor) 3  24 mm to proximal
LCX and a sirolimus eluting stent (Cypher) 2.5 28mm to OM1
branch. Procedure was uncomplicated and the patient was
discharged on dual antiplatelet therapy (aspirin and
clopidogrel).
Patient was on a regular follow up after the procedure and
was continuedwith long-termdual antiplatelet therapy due to
a high-risk profile. In October 2009 patient developed chest
discomfort, electrocardiogram (ECG) done subsequently was
suggestive of acute inferior STEMI. Angiography done thisreserved.
Fig. 2 e Lesion crossed with a guide wire. Thrombectomy
catheter did not cross the stent.
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OM1 stents. The LAD stent was patent with no evidence of any
aneurysm. plain old balloon angioplasty (POBA) was done to
the culprit lesion followed by IV bolus of t-pa within 4 hours of
symptoms. Patient recovered from procedure without
complication. A check angiography was not done.
After this event patient continued on dual antiplatelet
therapy along with statins, beta blocker and anti-ischemic
therapy. TMT done in August 2010 was negative for RMI.
Echocardiography showed an inferior wall hypokinesia and
left ventricular ejection fraction (LVEF) 50%. In August 2013, 7
years after the first procedure patient had acute onset chest
discomfort. Patient presented to hospital within 3 hours of
onset of symptoms. ECG donewas suggestive of acute anterior
wall STEMI. He was immediately shifted to catheterization
laboratory for primary angioplasty. Angiography done showed
LAD in stent thrombosis with an aneurysm at proximal end of
stent. There was angiographic visible thrombus in the stent
and the vessel distal to it (Fig. 1). The guide wire initially went
proximally between the malapposed stent and the vessel wall
(Fig. 2). Although a 2 mm balloon went through the thrombo-
suction catheter did not go. Anotherwirewas takenwhichwas
navigated through the correct path (Fig. 3). A thrombosuction
followed by administration of intracoronary abciximab was
done which made the vessel look angiographically free of
thrombus (Fig. 4). Lesionwaspredilatedwith212mmballoon
at 20 ATM and with 3  10 mm balloon at 10 ATM. The whole
length was stented using a mesh-covered MGuard stent
3.5  29 mm (Inspire MD) deployed at 10 ATM. This was post
dilatedwith 4 12mmballoonat the site of the aneurysmwith
good angiographic result (Fig. 5). There was no slow flow
encountered during the procedure. The thrombolysis in
myocardial infarction (TIMI) flow was three at the end of the
procedure. Patient became asymptomatic andwas discharged
in stable condition after 48 hours. The LVEF at discharge was
35%withahypokinetic anteriorwall. Clopidogrelwas changed
to prasugrel and aspirin continued. Atorvastatin dose wasFig. 1 e Aneurysm at the proximal end of the stent and
angiographically. Visible thrombus.increased to 80 mg, beta blockers and angiotensin converting
enzyme inhibitors (ACEI)were continued in appropriate doses.
4 weeks following the procedure he is asymptomatic.3. Discussion
Coronary artery aneurysms are a rare complication of coro-
nary stenting, whose true incidence, clinical course, and
treatment are largely unknown. Data on coronary aneurysms
are derived mainly from case reports and is uncommon, oc-
curs in less than 5% of coronary angiographic series.3 Coro-
nary aneurysms have been detected from as early as 3 daysFig. 3 e Two guide wires through the stent. The lower wire
is through the wall of the aneurysm andmal opposed stent
Fig. 4 e Angiography frame after thrombosuction and
intracoronary abciximab.
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stent (BMS) implantation.5 As reported in literature sirolimus
and paclitaxel DES are more commonly associated with an-
eurysms formation.6,7
There are a number of postulated causes of DES related
coronary artery aneurysms, the antiproliferative drugs along
with presence of a polymer can cause delayed re-
endothelialization, inflammatory changes in the media of
artery and hypersensitivity reactions, all of which can result
in coronary artery aneurysm formation.8 Coronary artery an-
eurysms can be associated with restenosis,9 whereas turbu-
lent and sluggish blood flow in the area of the aneurysm alongFig. 5 e Final picture after deploying MGuard stent with
TIMI 3 flow.with metallic stent, can predispose patients to the risk of
ST.10,11
In the study by Ong et al12 reported two patients with stent
thrombosis presenting as acute STEMI. These patients’
angiographic appearances suggested the presence of coronary
aneurysm formation with the guide wire passing between the
outside of the stent and the vessel wall. These events occurred
25 and 26 months after paclitaxel-eluting stent (PES) implan-
tation. In our case, the guidewire also initially passed between
the wall of the aneurysm and the malapposed stent. This was
corrected subsequently.
Feres et al10 published two cases of late stent thrombosis
(LST) occurring 40 months after SES and 12 months after PES
implantation. In both cases there was late-acquired incom-
plete stent apposition. The incidence of late-acquired stent
malapposition has been more commonly noted with DES
compared with BMS.13 Virmani et al14 reported a fatal case of
LST 18 months after SES implantation associated with a
localized hypersensitivity reaction and coronary aneurysm
formation. Coronary artery aneurysm can also present as an
intense local and systemic inflammatory response usually of
infective etiology, early after stent implantation.15
We have previously reported two case reports of coronary
artery aneurysms following sirolimus eluting stent implan-
tation and one case of coronary stent fracture resulting in
pseudoaneurysm formation.4,16,17 In the first case report two
patients developed coronary aneurysms within one month
after Sirolimus stent implantation requiring surgical inter-
vention.4 In the second case report large aneurysms were
detected at both the proximal and distal ends of the sirolimus
stent six months after stent implantation requiring surgery.16
The present cases had two episodes of VLST first at 2 years
and then again at 7 years post-DES deployment. Notably, both
episodes occurred while the patient was on dual antiplatelet
treatment. This may be related to polymer hypersensitivity of
the durable polymer in the stent system as the drug disap-
pears within a few months. The second episode of ST may be
related to coronary vessel remodeling after DES deployment
presenting as an aneurysm formation with stagnation of
blood.
To determine the long-term safety continued surveillance
after DES implantation is required. Recent improvement in
design of DES, absorbable polymer coatings and bio-
absorbable DES may prevent this complication from
occurring.Conflicts of interest
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